Anokion

Anokion

Biotechnology, Epfl Innovation Park-L 1a Chemin De La Dent d'Oche, Cambridge, , 1024, Massachusetts, United States, 11-50 Employees

anokion.com

  • facebook
  • LinkedIn

phone no Phone Number: 85********

Who is ANOKION

Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The...

Read More

map
  • Epfl Innovation Park-L 1a Chemin De La Dent d'Oche, Cambridge, Massachusetts, 1024, United States Headquarters: Epfl Innovation Park-L 1a Chemin De La Dent d'Oche, Cambridge, Massachusetts, 1024, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • Deb Geraghty CEO:   Deb Geraghty

industries-icon Industry: Biotechnology

SIC SIC Code: 4959 | NAICS Code: 541611 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ANOKION

Anokion Org Chart and Mapping

Deb Geraghty

President, Chief Executive Officer

Employees

Augustina Gyimah

Director Regulatory Affairs

Brenda Cahill

Senior Research Associate

Sean Smith

Senior Development Associate

Mike Dileo

Senior Vice President of Corporate Development & Business Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Anokion

Answer: Anokion's headquarters are located at Epfl Innovation Park-L 1a Chemin De La Dent d'Oche, Cambridge, , 1024, Massachusetts, United States

Answer: Anokion's phone number is 85********

Answer: Anokion's official website is https://anokion.com

Answer: Anokion's revenue is $10 Million to $25 Million

Answer: Anokion's SIC: 4959

Answer: Anokion's NAICS: 541611

Answer: Anokion has 11-50 employees

Answer: Anokion is in Biotechnology

Answer: Anokion contact info: Phone number: 85******** Website: https://anokion.com

Answer: Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokions distinct approach leverages the companys immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access